No Data
No Data
Morgan Stanley Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $218
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Ionis Pharmaceuticals (IONS) and Amicus (FOLD)
Dividend Roundup: Pfizer, Caterpillar, PNC Financial, AbbVie, and More
AbbVie (ABBV) Stock Moves -0.21%: What You Should Know
If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today
Possible Bearish Signals With AbbVie Insiders Disposing Stock
loading...
No Data
No Data